Geneos Wealth Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-240
| Closed | -$1K | – | 2423 |
|
|
2022
Q2 | $1K | Hold |
240
| – | – | ﹤0.01% | 2522 |
|
|
2022
Q1 | $2K | Hold |
240
| – | – | ﹤0.01% | 2561 |
|
|
2021
Q4 | $4K | Hold |
240
| – | – | ﹤0.01% | 2472 |
|
|
2021
Q3 | $6K | Hold |
240
| – | – | ﹤0.01% | 2403 |
|
|
2021
Q2 | $8K | Hold |
240
| – | – | ﹤0.01% | 2289 |
|
|
2021
Q1 | $7K | Hold |
240
| – | – | ﹤0.01% | 2542 |
|
|
2020
Q4 | $7K | Buy |
+240
| New | +$7K | ﹤0.01% | 2374 |
|
|
2019
Q4 | – | Sell |
-5,600
| Closed | -$29K | – | 2569 |
|
|
2019
Q3 | $29K | Hold |
5,600
| – | – | ﹤0.01% | 1444 |
|
|
2019
Q2 | $33K | Hold |
5,600
| – | – | ﹤0.01% | 1396 |
|
|
2019
Q1 | $40K | Sell |
5,600
-8,000
| -59% | -$57.1K | ﹤0.01% | 1250 |
|
|
2018
Q4 | $99K | Hold |
13,600
| – | – | 0.01% | 836 |
|
|
2018
Q3 | $73K | Hold |
13,600
| – | – | ﹤0.01% | 1002 |
|
|
2018
Q2 | $48K | Hold |
13,600
| – | – | ﹤0.01% | 1071 |
|
|
2018
Q1 | $27K | Hold |
13,600
| – | – | ﹤0.01% | 1260 |
|
|
2017
Q4 | $35K | Buy |
13,600
+8,750
| +180% | +$22.5K | ﹤0.01% | 1163 |
|
|
2017
Q3 | $25K | Hold |
4,850
| – | – | ﹤0.01% | 1245 |
|
|
2017
Q2 | $17K | Hold |
4,850
| – | – | ﹤0.01% | 1340 |
|
|
2017
Q1 | $25K | Buy |
4,850
+750
| +18% | +$3.87K | ﹤0.01% | 1162 |
|
|
2016
Q4 | $15K | Buy |
+4,100
| New | +$15K | ﹤0.01% | 1300 |
|